Abstract LB192: MTL-CEBPA in combination with pembrolizumab converts an immune desert to an inflamed TME in solid tumors resistant to checkpoint blockade
Plummer, Ruth, Sodergren, Mikael, Ryan, Brid, Tchakov, Ilian, Raulf, Nina, Hodgson, Rose, Tan, CP, Nicholls, Joanna P., Adderkin, Alison, Vasileiadou, N, Reebye, Vikash, Meyer, Tim, Pinato, David J., Sarker, Debashis, Basu, Bristi, Blagden, Sarah, Cook, Natalie, Evans, Jeff, Yachnin, Jeffrey, Chee, Cheng Ean, Li, Dan, El-Khoueiry, Anthony, Diab, Maria, Huang, Kai-Wen, Noel, Marcus S., Keenan, Bridget, Mahalingam, Devalingam, Grosso, Melanie, Arnaud, Denis, Auguste, Aurelie, Storkholm, Jan, McNeish, Iain, Habib, Robert, Rossi, John J., Habib, Nagy
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article